← All episodes

Will AI discover the next generation of medicines? | Masters of Scale Summit 2025

| 3 products mentioned
Masters of Scale Masters of Scale host
Watch on YouTube artificial intelligence drug discovery gene editing crispr cancer treatment rare diseases molecular biology

This Masters of Scale Summit panel explores how AI and gene editing technologies are revolutionizing drug discovery and medicine. Featuring discussions on CRISPR gene editing and AI-driven molecular discovery, the speakers debate whether these tools can accelerate the development of treatments for cancer, rare diseases, and global health challenges while addressing practical challenges around data quality, scalability, and implementation.

Key takeaways
  • • CRISPR gene editing has already demonstrated efficacy in curing genetic diseases and is moving toward prevention-focused applications, with near-term global impact expected in agriculture and climate solutions like methane reduction.
  • • AI-powered drug discovery requires foundation models that can generate entirely new molecules rather than just searching existing libraries, a capability that is rapidly advancing but remains computationally challenging.
  • • A major bottleneck in AI-driven biology is data harmonization—most biological datasets are measured inconsistently and difficult to combine, making it hard for AI systems to learn effectively without human curation.
  • • AlphaFold, a Nobel Prize-winning tool, has become essential for predicting protein structures and molecular interactions, enabling researchers to visualize how drugs might interfere with disease targets.
  • • Combination therapies are critical for preventing drug resistance in cancer treatment, but developing multiple drugs simultaneously requires an integrated AI system rather than competing pharmaceutical companies.
  • • Future medicine will likely feature cheaper, globally distributed therapeutics, with gene therapies moving from $600,000 in the US to $40,000 in emerging markets, similar to the PC revolution.

Recommendations (1)

AlphaFold
AlphaFold uses

"That's a technology that we now we and probably most other biologists that are doing molecular work use almost daily in the laboratory"

Jennifer Doudna · ▶ 11:41

Mentioned (2)

Herceptin "Antibodies for instance like Herceptin which is for breast cancer" ▶ 5:22
Rituximab "Rituximab which is for lymphoma and others that you might be taking for asthma or other diseases" ▶ 5:28

More from these creators

Harvard Professor Arthur Brooks on the simulation we're living in | Masters of Scale

Masters of Scale · Mar 27, 2026 · 1 rec

Amy Webb on the forces transforming society right now | Masters of Scale

Masters of Scale · Mar 20, 2026 · 2 recs

FanDuel CEO Amy Howe: ‘My whole career has been sliding doors moments’ | Masters of Scale

Masters of Scale · Mar 12, 2026